NewsPronto

 
Men's Weekly

.

ACN Newswire

Read more press releases from ACN Newswire here

Transgene and NEC Demonstrate High Accuracy of AI-based Neoantigen Prediction for the Design of Individualized Cancer Vaccine TG4050

  • Written by ACN Newswire

image

TOKYO, May 15, 2020 - (JCN Newswire) - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation (TSE: 6701), a leader in IT and network technologies, today announce that they will present data demonstrating that the prediction algorithm used to...

Read more: Transgene and NEC Demonstrate High Accuracy of AI-based Neoantigen Prediction for the Design of...